Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement from the American Heart Association

Circulation

Volumn 132, Issue 10, 2015, Pages 965-986

  Goldstein, Benjamin I ^a   Carnethon, Mercedes R ^a   Matthews, Karen A ^a   McIntyre, Roger S ^a   Miller, Gregory E ^a   Raghuveer, Geetha ^a   Stoney, Catherine M ^a   Wasiak, Hank ^a   McCrindle, Brian W ^a  

^a NONE

Author keywords

adolescent; AHA Scientific Statements; atherosclerosis; bipolar disorder; cardiovascular diseases; coronary artery disease; depressive disorder, major; population at risk

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; AUTONOMIC DYSFUNCTION; BEHAVIOR; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; HEALTH EDUCATION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MAJOR DEPRESSION; MEDICAL SOCIETY; META ANALYSIS (TOPIC); MOOD DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEDENTARY LIFESTYLE; SLEEP DISORDER; SMOKING; SUBSTANCE USE; YOUNG ADULT; ADVERSE EFFECTS; AGE; CARDIOVASCULAR DISEASES; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; DISEASE COURSE; DISEASE PREDISPOSITION; PRACTICE GUIDELINE; PSYCHOLOGY; RISK FACTOR; STANDARDS; UNITED STATES;

ADOLESCENT; AGE FACTORS; AMERICAN HEART ASSOCIATION; ATHEROSCLEROSIS; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SMOKING; UNITED STATES;

EID: 84941355397     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000229     Document Type: Article

References (271)

1. Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation. 2006;114:2710-2738. doi: 10.1161/CIRCULATIONAHA.106.179568.
2. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213-S256. doi: 10.1542/peds.2009-2107C.
3. Frasure-Smith N, Lespance F. Reflections on depression as a cardiac risk factor. Psychosom Med. 2005;67(suppl 1):S19-S25. doi: 10.1097/01. psy.0000162253.07959.db.
4. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580-592.
5. Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord. 2009;11:657-662. doi: 10.1111/j.1399-5618.2009.00735.x.
6. McCaffery JM, Duan QL, Frasure-Smith N, Barhdadi A, Lespance F, Thoux P, Rouleau GA, DubMP. Genetic predictors of depressive symptoms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet. 2009;150B:381-388. doi: 10.1002/ajmg.b.30824.
7. Vaccarino V, Votaw J, Faber T, Veledar E, Murrah NV, Jones LR, Zhao J, Su S, Goldberg J, Raggi JP, Quyyumi AA, Sheps DS, Bremner JD. Major depression and coronary flow reserve detected by positron emission tomography. Arch Intern Med. 2009;169:1668-1676. doi: 10.1001/archinternmed.2009.330.
8. Mannie ZN, Williams C, Diesch J, Steptoe A, Leeson P, Cowen PJ. Cardiovascular and metabolic risk profile in young people at familial risk of depression. Br J Psychiatry. 2013;203:18-23. doi: 10.1192/bjp. bp.113.126987.
9. Rottenberg J, Yaroslavsky I, Carney RM, Freedland KE, George CJ, Baji I, Dochnal R, Goros J, Halas K, Kapornai K, Kiss E, Osvh V, Varga H, VetrA, Kovacs M. The association between major depressive disorder in childhood and risk factors for cardiovascular disease in adolescence. Psychosom Med. 2014;76:122-127. doi: 10.1097/PSY.0000000000000028.
10. Osby U, Brandt L, Correia N, Ekbom A, Spar P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58:844-850.
11. Weeke A, Juel K, Vaeth M. Cardiovascular death and manic-depressive psychosis. J Affect Disord. 1987;13:287-292.
12. Westman J, Hlgren J, Wahlbeck K, Erlinge D, Alfredsson L, Osby U. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open. 2013;3:e002373. doi: 10.1136/bmjopen-2012-002373.
13. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested casecontrol study. Arch Gen Psychiatry. 2007;64:1368-1376. doi: 10.1001/archpsyc.64.12.1368.
14. Tsuang MT, Woolson RF, Fleming JA. Causes of death in schizophrenia and manic-depression. Br J Psychiatry. 1980;136:239-242.
15. Fiedorowicz JG, Solomon DA, Endicott J, Leon AC, Li C, Rice JP, Coryell WH. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med. 2009;71:598-606. doi: 10.1097/PSY.0b013e3181acee26.
16. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ, Huang B. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:1205-1215.
17. Goldstein BI, Liu SM, Zivkovic N, Schaffer A, Chien LC, Blanco C. The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord. 2011;13:387-395. doi: 10.1111/j.1399-5618.2011.00932.x.
18. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St Clair D, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N; Wellcome Trust Case Control Consortium. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008;40:1056-1058. doi: 10.1038/ng.209.
19. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM. Whole-genome association study of bipolar disorder. Mol Psychiatry. 2008;13:558-569. doi: 10.1038/sj.mp.4002151.
20. Beitelshees AL, Navare H, Wang D, Gong Y, Wessel J, Moss JI, Langaee TY, Cooper-DeHoff RM, Sadee W, Pepine CJ, Schork NJ, Johnson JA. CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response. Circ Cardiovasc Genet. 2009;2:362-370. doi: 10.1161/CIRCGENETICS.109.857839.
21. Jung C, GenGG, Tom M, Plata C, Selent J, Pastor M, Fandos C, Senti M, Lucas G, Elosua R, Valverde MA. A gain-of-function SNP in TRPC4 cation channel protects against myocardial infarction. Cardiovasc Res. 2011;91:465-471. doi: 10.1093/cvr/cvr083.
22. Gore FM, Bloem PJ, Patton GC, Ferguson J, Joseph V, Coffey C, Sawyer SM, Mathers CD. Global burden of disease in young people aged 10-24 years: a systematic analysis [published correction appears in Lancet. 2011;378:486]. Lancet. 2011;377:2093-2102. doi: 10.1016/S0140-6736(11)60512-6.
23. APA. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
24. US Preventive Services Task Force. Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force recommendation statement [published correction appears in Pediatrics. 2009;123:1611]. Pediatrics. 2009;123:1223-1228. doi: 10.1542/peds.2008-2381.
25. Zuckerbrot RA, Cheung AH, Jensen PS, Stein RE, Laraque D; GLAD-PC Steering Group. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I: identification, assessment, and initial management. Pediatrics. 2007;120:e1299-e1312. doi: 10.1542/peds.2007-1144.
26. McClellan J, Kowatch R, Findling RL; Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder [published correction appears in J Am Acad Child Adolesc Psychiatry. 2007;46:786]. J Am Acad Child Adolesc Psychiatry. 2007;46:107-125. doi: 10.1097/01.chi.0000242240.69678.c4.
27. Goldstein BI. Recent progress in understanding pediatric bipolar disorder. Arch Pediatr Adolesc Med. 2012;166:362-371. doi: 10.1001/archpediatrics.2011.832.
28. Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49:980-989. doi: 10.1016/j.jaac.2010.05.017.
29. Goldstein BI, Levitt AJ. Further evidence for a developmental subtype of bipolar disorder defined by age at onset: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Psychiatry. 2006;163:1633-1636. doi: 10.1176/appi.ajp.163.9.1633.
30. Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, Bowden CL, Sachs GS, Nierenberg AA; STEP-BD Investigators. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry. 2004;55:875-881. doi: 10.1016/j.biopsych.2004.01.022.
31. Leverich GS, Post RM, Keck PE Jr, Altshuler LL, Frye MA, Kupka RW, Nolen WA, Suppes T, McElroy SL, Grunze H, Denicoff K, Moravec MK, Luckenbaugh D. The poor prognosis of childhood-onset bipolar disorder. J Pediatr. 2007;150:485-490. doi: 10.1016/j.jpeds.2006.10.070.
32. Korczak DJ, Goldstein BI. Childhood onset major depressive disorder: course of illness and psychiatric comorbidity in a community sample. J Pediatr. 2009;155:118-123. doi: 10.1016/j.jpeds.2009.01.061.
33. Zisook S, Rush AJ, Lesser I, Wisniewski SR, Trivedi M, Husain MM, Balasubramani GK, Alpert JE, Fava M. Preadult onset vs. adult onset of major depressive disorder: a replication study. Acta Psychiatr Scand. 2007;115:196-205. doi: 10.1111/j.1600-0447.2006.00868.x.
34. Klein DN, Schatzberg AF, McCullough JP, Dowling F, Goodman D, Howland RH, Markowitz JC, Smith C, Thase ME, Rush AJ, LaVange L, Harrison WM, Keller MB. Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord. 1999;55:149-157.
35. Geller B, Tillman R, Bolhofner K, Zimerman B. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry. 2008;65:1125-1133. doi: 10.1001/archpsyc.65.10.1125.
36. Thapar A, Collishaw S, Pine DS, Thapar AK. Depression in adolescence. Lancet. 2012;379:1056-1067. doi: 10.1016/S0140-6736(11)60871-4.
37. Shah AJ, Veledar E, Hong Y, Bremner JD, Vaccarino V. Depression and history of attempted suicide as risk factors for heart disease mortality in young individuals. Arch Gen Psychiatry. 2011;68:1135-1142. doi: 10.1001/archgenpsychiatry.2011.125.
38. Huang KL, Su TP, Chen TJ, Chou YH, Bai YM. Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study. Psychiatry Clin Neurosci. 2009;63:401-409. doi: 10.1111/j.1440-1819.2009.01974.x.
39. Elovainio M, Keltikangas-Jvinen L, Kivimi M, Pulkki L, Puttonen S, Heponiemi T, Juonala M, Viikari JS, Raitakari OT. Depressive symptoms and carotid artery intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study. Psychosom Med. 2005;67:561-567. doi: 10.1097/01.psy.0000170340.74035.23.
40. Dietz LJ, Matthews KA. Depressive symptoms and subclinical markers of cardiovascular disease in adolescents. J Adolesc Health. 2011;48:579-584. doi: 10.1016/j.jadohealth.2010.09.001.
41. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B. Abnormal brachial artery flow-mediated vasodilation in young adults with major depression [published correction appears in Am J Cardiol. 2001;88:722]. Am J Cardiol. 2001;88:196-198, A7.
42. Garc RG, Zarruk JG, Barrera C, Pinz A, Trillos E, Arenas WD, Luengas C, Tomaz C, Lez-Jaramillo P. Plasma nitrate levels and flowmediated vasodilation in untreated major depression. Psychosom Med. 2011;73:344-349. doi: 10.1097/PSY.0b013e31821566cf.
43. Murray DP, Metz NS, Haynes WG, Fiedorowicz JG. Vascular function is not impaired early in the course of bipolar disorder. J Psychosom Res. 2012;72:195-198. doi: 10.1016/j.jpsychores.2011.12.006.
44. Osika W, Montgomery SM, Dangardt F, Wrborg P, Gan LM, Tideman E, Friberg P. Anger, depression and anxiety associated with endothelial function in childhood and adolescence. Arch Dis Child. 2011;96:38-43. doi: 10.1136/adc.2008.152777.
45. Tomfohr LM, Murphy ML, Miller GE, Puterman E. Multiwave associations between depressive symptoms and endothelial function in adolescent and young adult females. Psychosom Med. 2011;73:456-461. doi: 10.1097/PSY.0b013e3182228644.
46. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med. 2002;23:51-61.
47. Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B; on behalf of the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association [published correction appears in Hypertension. 2010;56:e36]. Hypertension. 2009;54:919-950. doi: 10.1161/HYPERTENSIONAHA.109.192639.
48. Battista M, Murray RD, Daniels SR. Use of the metabolic syndrome in pediatrics: a blessing and a curse. Semin Pediatr Surg. 2009;18:136-143. doi: 10.1053/j.sempedsurg.2009.04.003.
49. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S; IDF Consensus Group. The metabolic syndrome in children and adolescents: an IDF consensus report. Pediatr Diabetes. 2007;8:299-306. doi: 10.1111/j.1399-5448.2007.00271.x.
50. McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CW, Taylor VH, Woldeyohannes HO, Alsuwaidan MT, Soczynska JK, Kim B, Lourenco MT, Kahn LS, Goldstein BI. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep. 2009;9:51-59.
51. McIntyre RS, Danilewitz M, Liauw SS, Kemp DE, Nguyen HT, Kahn LS, Kucyi A, Soczynska JK, Woldeyohannes HO, Lachowski A, Kim B, Nathanson J, Alsuwaidan M, Taylor VH. Bipolar disorder and metabolic syndrome: an international perspective. J Affect Disord. 2010;126:366-387. doi: 10.1016/j.jad.2010.04.012.
52. Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P, Probst M, De Hert M. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry. 2013;170:265-274. doi: 10.1176/appi. ajp.2012.12050620.
53. Goldstein BI, Birmaher B, Axelson DA, Goldstein TR, Esposito-Smythers C, Strober MA, Hunt J, Leonard H, Gill MK, Iyengar S, Grimm C, Yang M, Ryan ND, Keller MB. Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. J Clin Psychiatry. 2008;69:1953-1959.
54. Jerrell JM, McIntyre RS, Tripathi A. A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. J Clin Psychiatry. 2010;71:1518-1525. doi: 10.4088/JCP.09m05585ora.
55. Evans-Lacko SE, Zeber JE, Gonzalez JM, Olvera RL. Medical comorbidity among youth diagnosed with bipolar disorder in the United States. J Clin Psychiatry. 2009;70:1461-1466. doi: 10.4088/JCP.08m04871.
56. Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry. 2007;46:687-700. doi: 10.1097/chi.0b013e318040b25f.
57. Correll CU. Elevated cardiovascular risk in patients with bipolar disorder: when does it start and where does it lead J Clin Psychiatry. 2008;69:1948-1952.
58. Jerrell JM, McIntyre RS. Metabolic, digestive, and reproductive adverse events associated with antimanic treatment in children and adolescents: a retrospective cohort study. Prim Care Companion J Clin Psychiatry. 2010;12:e1-e8. doi: 10.4088/PCC.09m00891ora.
59. Pulkki-Rack L, Elovainio M, Kivimi M, Mattsson N, Raitakari OT, Puttonen S, Marniemi J, Viikari JS, Keltikangas-Jvinen L. Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study. Health Psychol. 2009;28:108-116. doi: 10.1037/a0012646.
60. Anderson SE, Cohen P, Naumova EN, Jacques PF, Must A. Adolescent obesity and risk for subsequent major depressive disorder and anxiety disorder: prospective evidence. Psychosom Med. 2007;69:740-747. doi: 10.1097/PSY.0b013e31815580b4.
61. Pine DS, Goldstein RB, Wolk S, Weissman MM. The association between childhood depression and adulthood body mass index. Pediatrics. 2001;107:1049-1056.
62. Merikangas AK, Mendola P, Pastor PN, Reuben CA, Cleary SD. The association between major depressive disorder and obesity in US adolescents: results from the 2001-2004 National Health and Nutrition Examination Survey. J Behav Med. 2012;35:149-154. doi: 10.1007/s10865-011-9340-x.
63. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry. 1996;53:391-399.
64. McIntyre RS, Alsuwaidan M, Goldstein BI, Taylor VH, Schaffer A, Beaulieu S, Kemp DE; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry. 2012;24:69-81.
65. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV, Lee HB, Lyketsos C. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751-2759. doi: 10.1001/jama.299.23.2751.
66. Timonen M, Rajala U, Jokelainen J, Keinen-Kiukaanniemi S, Meyer-Rochow VB, Ren P. Depressive symptoms and insulin resistance in young adult males: results from the Northern Finland 1966 birth cohort. Mol Psychiatry. 2006;11:929-933. doi: 10.1038/sj.mp.4001838.
67. Timonen M, Salmenkaita I, Jokelainen J, Laakso M, Hken P, Koskela P, Meyer-Rochow VB, Peitso A, Keinen-Kiukaanniemi S. Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Psychosom Med. 2007;69:723-728. doi: 10.1097/PSY.0b013e318157ad2e.
68. Reynolds KA, Helgeson VS. Children with diabetes compared to peers: depressed Distressed A meta-analytic review. Ann Behav Med. 2011;42:29-41. doi: 10.1007/s12160-011-9262-4.
69. Lawrence JM, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, Liese AD, Bell RA, Waitzfelder BE, McKeown RE; SEARCH for Diabetes in Youth Study. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics. 2006;117:1348-1358. doi: 10.1542/peds.2005-1398.
70. Jerrell JM, Tripathi A, Rizvi AA, McIntyre RS. The risk of developing type 2 diabetes mellitus associated with psychotropic drug use in children and adolescents: a retrospective cohort analysis. Prim Care Companion CNS Disord. 2012;14(1). doi: 10.4088/PCC.11m01185.
71. Enger C, Jones ME, Kryzhanovskaya L, Doherty M, McAfee AT. Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia. Int J Adolesc Med Health. 2013;25:3-11. doi: 10.1515/ijamh-2013-0002.
72. Patel NC, Hariparsad M, Matias-Akthar M, Sorter MT, Barzman DH, Morrison JA, Stanford KE, Strakowski SM, DelBello MP. Body mass indexes and lipid profiles in hospitalized children and adolescents exposed to atypical antipsychotics. J Child Adolesc Psychopharmacol. 2007;17:303-311. doi: 10.1089/cap.2006.0037.
73. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003;54:227-240.
74. Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG. Mania and mortality: why the excess cardiovascular risk in bipolar disorder Curr Psychiatry Rep. 2009;11:475-480.
75. Goldstein BI, Kemp DE, Soczynska JK, McIntyre RS. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry. 2009;70:1078-1090. doi: 10.4088/JCP.08r04505.
76. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24-31. doi: 10.1016/j.it.2005.11.006.
77. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65:732-741. doi: 10.1016/j.biopsych.2008.11.029.
78. Smith RS. The macrophage theory of depression [published correction appears in Med Hypotheses. 1991;36:178]. Med Hypotheses. 1991;35:298-306.
79. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanct KL. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446-457. doi: 10.1016/j.biopsych.2009.09.033.
80. Munkholm K, Vinberg M, Vedel Kessing L. Cytokines in bipolar disorder: a systematic review and meta-analysis. J Affect Disord. 2013;144:16-27. doi: 10.1016/j.jad.2012.06.010.
81. Munkholm K, Braer JV, Kessing LV, Vinberg M. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013;47:1119-1133. doi: 10.1016/j. jpsychires.2013.05.018.
82. Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74:15-25. doi: 10.1016/j.biopsych.2013.01.007.
83. Wong ML, Dong C, Maestre-Mesa J, Licinio J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry. 2008;13:800-812. doi: 10.1038/mp.2008.59.
84. Kaminsky Z, Tochigi M, Jia P, Pal M, Mill J, Kwan A, Ioshikhes I, Vincent JB, Kennedy JL, Strauss J, Pai S, Wang SC, Petronis A. A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder. Mol Psychiatry. 2012;17:728-740. doi: 10.1038/mp.2011.64.
85. Barkhudaryan N, Dunn AJ. Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis. Neurochem Res. 1999;24:1169-1180.
86. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009;66:407-414. doi: 10.1016/j.biopsych.2009.03.015.
87. Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010;15:384-392. doi: 10.1038/mp.2009.47.
88. Mills NT, Scott JG, Wray NR, Cohen-Woods S, Baune BT. Research review: the role of cytokines in depression in adolescents: a systematic review. J Child Psychol Psychiatry. 2013;54:816-835.
89. Henje Blom E, Lekander M, Ingvar M, sberg M, Mobarrez F, Serlachius E. Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. J Affect Disord. 2012;136:716-723. doi: 10.1016/j.jad.2011.10.002.
90. Gabbay V, Klein RG, Alonso CM, Babb JS, Nishawala M, De Jesus G, Hirsch GS, Hottinger-Blanc PM, Gonzalez CJ. Immune system dysregulation in adolescent major depressive disorder. J Affect Disord. 2009;115:177-182. doi: 10.1016/j.jad.2008.07.022.
91. Chaiton M, O'Loughlin J, Karp I, Lambert M. Depressive symptoms and C-reactive protein are not associated in a population-based sample of adolescents. Int J Behav Med. 2010;17:216-222. doi: 10.1007/s12529-010-9078-9.
92. Hood KK, Lawrence JM, Anderson A, Bell R, Dabelea D, Daniels S, Rodriguez B, Dolan LM; SEARCH for Diabetes in Youth Study Group. Metabolic and inflammatory links to depression in youth with diabetes. Diabetes Care. 2012;35:2443-2446. doi: 10.2337/dc11-2329.
93. Rohleder N, Miller GE. Acute deviations from long-term trait depressive symptoms predict systemic inflammatory activity. Brain Behav Immun. 2008;22:709-716. doi: 10.1016/j.bbi.2007.10.012.
94. Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:952-955. doi: 10.1016/j.pnpbp.2007.02.018.
95. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN. Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder. Int J Neuropsychopharmacol. 2009;12:447-458. doi: 10.1017/S1461145708009310.
96. Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, de Ridder D, Kupka RW, Nolen WA, Drexhage HA. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry. 2008;65:395-407. doi: 10.1001/archpsyc.65.4.395.
97. Goldstein BI, Collinger KA, Lotrich F, Marsland AL, Gill MK, Axelson DA, Birmaher B. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Child Adolesc Psychopharmacol. 2011;21:479-484. doi: 10.1089/cap.2011.0009.
98. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207. doi: 10.1056/NEJMoa0807646.
99. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK; for the Pediatric Rheumatology Collaborative Study Group. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med. 2000;342:763-769. doi: 10.1056/NEJM200003163421103.
100. Ridker PM. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev. 2007;65(pt 2):S253-S259.
101. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med. 2008;264:295-314. doi: 10.1111/j.1365-2796.2008.02015.x.
102. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and metaanalyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:483-495.
103. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46-56. doi: 10.1038/nrn2297.
104. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001;344:961-966. doi: 10.1056/NEJM200103293441303.
105. Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology. 2001;26:797-808.
106. Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70:31-41. doi: 10.1001/2013.jamapsychiatry.4.
107. Glassman AH, Miller GE. Where there is depression, there is inflammation... sometimes! Biol Psychiatry. 2007;62:280-281. doi: 10.1016/j. biopsych.2007.05.032.
108. Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun. 2002;16:1-16. doi: 10.1006/brbi.2001.0654.
109. Miller GE, Cole SW. Clustering of depression and inflammation in adolescents previously exposed to childhood adversity. Biol Psychiatry. 2012;72:34-40. doi: 10.1016/j.biopsych.2012.02.034.
110. Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry. 2012;71:15-21. doi: 10.1016/j. biopsych.2011.09.023.
111. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
112. Sies H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91:31S-38S.
113. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009;73:411-418.
114. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962. doi: 10.1056/NEJMoa013591.
115. Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M, Tabit CE, Hamburg NM, Frame AA, Caiano TL, Kluge MA, Duess MA, Levit A, Kim B, Hartman ML, Joseph L, Shirihai OS, Vita JA. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation. 2011;124:444-453. doi: 10.1161/CIRCULATIONAHA.110.014506.
116. Maas R, Schwedhelm E, Kahl L, Li H, Benndorf R, Leburg N, Fstermann U, Ber RH. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia. Clin Chem. 2008;54:292-300. doi: 10.1373/clinchem.2007.093575.
117. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Mzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease [published correction appears in Circulation. 2003;108:500]. Circulation. 2001;104:2673-2678.
118. Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Ceres KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Gonlves CA. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res. 2007;41:523-529. doi: 10.1016/j. jpsychires.2006.07.013.
119. Andreazza AC, Kauer-Sant'anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, Yatham LN. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord. 2008;111:135-144. doi: 10.1016/j. jad.2008.04.013.
120. Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant'Anna M, Cunha AB, Post RM. Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr. 2008;30:243-245.
121. Szuster-Ciesielska A, Sotwiska M, Stachura A, Marmurowska-Michaowska H, Dubas-Slemp H, Bojarska-Junak A, Kandefer-Szersze M. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:686-694. doi: 10.1016/j.pnpbp.2007.11.012.
122. Chung CP, Schmidt D, Stein CM, Morrow JD, Salomon RM. Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res. 2013;206:213-216. doi: 10.1016/j. psychres.2012.10.018.
123. Gibson SA, Korade Ž, Shelton RC. Oxidative stress and glutathione response in tissue cultures from persons with major depression. J Psychiatr Res. 2012;46:1326-1332. doi: 10.1016/j.jpsychires. 2012.06.008.
124. Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:676-692. doi: 10.1016/j.pnpbp.2010.05.004.
125. Palta P, Samuel LJ, Miller ER 3rd, Szanton SL. Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom Med. 2014;76:12-19. doi: 10.1097/PSY.0000000000000009.
126. Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot Essent Fatty Acids. 2003;69:393-399.
127. Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC. The effect of risperidone treatment on superoxide dismutase in schizophrenia. J Clin Psychopharmacol. 2003;23:128-131.
128. Dakhale G, Khanzode S, Khanzode S, Saoji A, Khobragade L, Turankar A. Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology. 2004;49:205-209.
129. Gergerlioglu HS, Savas HA, Bulbul F, Selek S, Uz E, Yumru M. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment [published correction appears in Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1345]. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:697-702. doi: 10.1016/j.pnpbp.2006.12.020.
130. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension. 1998;32:293-297.
131. Liao D, Cai J, Barnes RW, Tyroler HA, Rautaharju P, Holme I, Heiss G. Association of cardiac autonomic function and the development of hypertension: the ARIC study. Am J Hypertens. 1996;9(pt 1):1147-1156.
132. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987-1998. Circulation. 2003;107:2190-2195. doi: 10.1161/01. CIR.0000066324.74807.95.
133. Carnethon MR, Jacobs DR Jr, Sidney S, Liu K; CARDIA study. Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care. 2003;26:3035-3041.
134. Carnethon MR, Prineas RJ, Temprosa M, Zhang ZM, Uwaifo G, Molitch ME; Diabetes Prevention Program Research Group. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care. 2006;29:914-919.
135. Carnethon MR, Yan L, Greenland P, Garside DB, Dyer AR, Metzger B, Daviglus ML. Resting heart rate in middle age and diabetes development in older age. Diabetes Care. 2008;31:335-339. doi: 10.2337/dc07-0874.
136. DiBona GF. The sympathetic nervous system and hypertension: recent developments. Hypertension. 2004;43:147-150. doi: 10.1161/01. HYP.0000113047.47711.fa.
137. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, Levy D. Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study. Circulation. 1996;94:2850-2855.
138. Liao D, Carnethon M, Evans GW, Cascio WE, Heiss G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the Atherosclerosis Risk In Communities (ARIC) study. Diabetes. 2002;51:3524-3531.
139. Carnethon MR, Liao D, Evans GW, Cascio WE, Chambless LE, Rosamond WD, Heiss G. Does the cardiac autonomic response to postural change predict incident coronary heart disease and mortality The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2002;155:48-56.
140. La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger JT Jr, Camm AJ, Schwartz PJ; on behalf of the Autonomic Tone and Reflexes After Myocardial Infarction (ATRAMI) Investigators.. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072-2077. doi: 10.1161/01. CIR.103.16.2072.
141. Byrne ML, Sheeber L, Simmons JG, Davis B, Shortt JW, Katz LF, Allen NB. Autonomic cardiac control in depressed adolescents. Depress Anxiety. 2010;27:1050-1056. doi: 10.1002/da.20717.
142. Bogner HR, Morales KH, de Vries HF, Cappola AR. Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med. 2012;10:15-22. doi: 10.1370/afm.1344.
143. Lustman PJ, Penckofer SM, Clouse RE. Recent advances in understanding depression in adults with diabetes. Curr Psychiatry Rep. 2008;10:495-502.
144. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003;26:2822-2828.
145. Miranda J, Bernal G, Lau A, Kohn L, Hwang WC, LaFromboise T. State of the science on psychosocial interventions for ethnic minorities. Annu Rev Clin Psychol. 2005;1:113-142. doi: 10.1146/annurev. clinpsy.1.102803.143822.
146. Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W. Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res. 2010;44:168-176. doi: 10.1016/j.jpsychires.2009.07.011.
147. Licht CM, de Geus EJ, Zitman FG, Hoogendijk WJ, van Dyck R, Penninx BW. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry. 2008;65:1358-1367. doi: 10.1001/archpsyc.65.12.1358.
148. Thayer JF, Fischer JE. Heart rate variability, overnight urinary norepinephrine, and plasma cholesterol in apparently healthy human adults. Int J Cardiol. 2013;162:240-244. doi: 10.1016/j.ijcard.2011.05.058.
149. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J. 2000;140(suppl):77-83.
150. Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry. 2010;67:1067-1074. doi: 10.1016/j.biopsych.2009.12.012.
151. Voss A, Baier V, Schulz S, Bar KJ. Linear and nonlinear methods for analyses of cardiovascular variability in bipolar disorders. Bipolar Disord. 2006;8(pt 1):441-452. doi: 10.1111/j.1399-5618.2006.00364.x
152. Clarke G, Harvey AG. The complex role of sleep in adolescent depression. Child Adolesc Psychiatr Clin N Am. 2012;21:385-400. doi: 10.1016/j.chc.2012.01.006.
153. Todder D, Bersudsky Y, Cohen H. Nonlinear analysis of RR interval in euthymic bipolar disorder. Auton Neurosci. 2005;117:127-131. doi: 10.1016/j.autneu.2004.11.006.
154. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, Czajkowski SM, O'Connor C, Stone PH, Freedland KE. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001;104:2024-2028.
155. Finkelhor D, Turner HA, Shattuck A, Hamby SL. Violence, crime, and abuse exposure in a national sample of children and youth: an update [published correction appears in JAMA Pediatr. 2014;168:286]. JAMA Pediatr. 2013;167:614-621. doi: 10.1001/jamapediatrics.2013.42.
156. Cicchetti D, Toth SL. Child maltreatment. Annu Rev Clin Psychol. 2005;1:409-438. doi: 10.1146/annurev.clinpsy.1.102803.144029.
157. Green JG, McLaughlin KA, Berglund PA, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC. Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry. 2010;67:113-123. doi: 10.1001/archgenpsychiatry.2009.186.
158. Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry. 2002;159:1133-1145.
159. Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in men. Am J Psychiatry. 2006;163:115-124. doi: 10.1176/appi.ajp.163.1.115.
160. McLaughlin KA, Greif Green J, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC. Childhood adversities and first onset of psychiatric disorders in a national sample of US adolescents. Arch Gen Psychiatry. 2012;69:1151-1160. doi: 10.1001/archgenpsychiatry.2011.2277.
161. Nanni V, Uher R, Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis [published correction appears in Am J Psychiatry. 2012;169:439]. Am J Psychiatry. 2012;169:141-151.
162. Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology. 2008;33:693-710. doi: 10.1016/j.psyneuen.2008.03.008.
163. Cicchetti D, Rogosch FA. Diverse patterns of neuroendocrine activity in maltreated children. Dev Psychopathol. 2001;13:677-693.
164. Danese A, Caspi A, Williams B, Ambler A, Sugden K, Mika J, Werts H, Freeman J, Pariante CM, Moffitt TE, Arseneault L. Biological embedding of stress through inflammation processes in childhood. Mol Psychiatry. 2011;16:244-246. doi: 10.1038/mp.2010.5.
165. Danese A, Pariante CM, Caspi A, Taylor A, Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA. 2007;104:1319-1324. doi: 10.1073/pnas.0610362104.
166. Danese A, Moffitt TE, Harrington H, Milne BJ, Polanczyk G, Pariante CM, Poulton R, Caspi A. Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med. 2009;163:1135-1143. doi: 10.1001/archpediatrics.2009.214.
167. Midei AJ, Matthews KA, Chang YF, Bromberger JT. Childhood physical abuse is associated with incident metabolic syndrome in mid-life women. Health Psychol. 2013;32:121-127. doi: 10.1037/a0027891.
168. Danese A, Tan M. Childhood maltreatment and obesity: systematic review and meta-analysis. Mol Psychiatry. 2014;19:544-554. doi: 10.1038/mp.2013.54.
169. McIntyre RS, Soczynska JK, Liauw SS, Woldeyohannes HO, Brietzke E, Nathanson J, Alsuwaidan M, Muzina DJ, Taylor VH, Cha DS, Kennedy SH. The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the International Mood Disorders Collaborative Project. Int J Psychiatry Med. 2012;43:165-177.
170. Dong M, Giles WH, Felitti VJ, Dube SR, Williams JE, Chapman DP, Anda RF. Insights into causal pathways for ischemic heart disease: adverse childhood experiences study. Circulation. 2004;110:1761-1766. doi: 10.1161/01.CIR.0000143074.54995.7F.
171. Rich-Edwards JW, Mason S, Rexrode K, Spiegelman D, Hibert E, Kawachi I, Jun HJ, Wright RJ. Physical and sexual abuse in childhood as predictors of early-onset cardiovascular events in women. Circulation. 2012;126:920-927. doi: 10.1161/CIRCULATIONAHA. 111.076877.
172. Wegman HL, Stetler C. A meta-analytic review of the effects of childhood abuse on medical outcomes in adulthood. Psychosom Med. 2009;71:805-812. doi: 10.1097/PSY.0b013e3181bb2b46.
173. Harvey AG, Mullin BC, Hinshaw SP. Sleep and circadian rhythms in children and adolescents with bipolar disorder. Dev Psychopathol. 2006;18:1147-1168. doi: 10.1017/S095457940606055X.
174. Harvey AG. The adverse consequences of sleep disturbance in pediatric bipolar disorder: implications for intervention. Child Adolesc Psychiatr Clin N Am. 2009;18:321-338, viii. doi: 10.1016/j.chc. 2008.11.006.
175. Robert JJ, Hoffmann RF, Emslie GJ, Hughes C, Rintelmann J, Moore J, Armitage R. Sex and age differences in sleep macroarchitecture in childhood and adolescent depression. Sleep. 2006;29:351-358.
176. Glozier N, Martiniuk A, Patton G, Ivers R, Li Q, Hickie I, Senserrick T, Woodward M, Norton R, Stevenson M. Short sleep duration in prevalent and persistent psychological distress in young adults: the DRIVE study. Sleep. 2010;33:1139-1145.
177. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and metaanalysis of prospective studies. Eur Heart J. 2011;32:1484-1492. doi: 10.1093/eurheartj/ehr007.
178. Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, Stranges S, Miller MA. Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 2008;31:619-626.
179. Matthews KA, Dahl RE, Owens JF, Lee L, Hall M. Sleep duration and insulin resistance in healthy black and white adolescents. Sleep. 2012;35:1353-1358. doi: 10.5665/sleep.2112.
180. Goldstein TR, Fersch-Podrat R, Axelson DA, Gilbert A, Hlastala SA, Birmaher B, Frank E. Early intervention for adolescents at high risk for the development of bipolar disorder: pilot study of Interpersonal and Social Rhythm Therapy (IPSRT). Psychotherapy (Chic). 2014;51:180-189. doi: 10.1037/a0034396.
181. Hickie IB, Naismith SL, Robillard R, Scott EM, Hermens DF. Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression. BMC Med. 2013;11:79. doi: 10.1186/1741-7015-11-79.
182. Martez-Gez D, Eisenmann JC, Gez-Martez S, Veses A, Marcos A, Veiga OL. Sedentary behavior, adiposity and cardiovascular risk factors in adolescents: the AFINOS study. Rev Esp Cardiol. 2010;63:277-285.
183. Chuang HT, Mansell C, Patten SB. Lifestyle characteristics of psychiatric outpatients. Can J Psychiatry. 2008;53:260-266.
184. Galper DI, Trivedi MH, Barlow CE, Dunn AL, Kampert JB. Inverse association between physical inactivity and mental health in men and women. Med Sci Sports Exerc. 2006;38:173-178.
185. Penninx BW, Leveille S, Ferrucci L, van Eijk JT, Guralnik JM. Exploring the effect of depression on physical disability: longitudinal evidence from the established populations for epidemiologic studies of the elderly. Am J Public Health. 1999;89:1346-1352.
186. Kilbourne AM, Rofey DL, McCarthy JF, Post EP, Welsh D, Blow FC. Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disord. 2007;9:443-452. doi: 10.1111/j.1399-5618.2007.00386.x.
187. Shah A, Alshaher M, Dawn B, Siddiqui T, Longaker RA, Stoddard MF, El-Mallakh R. Exercise tolerance is reduced in bipolar illness. J Affect Disord. 2007;104:191-195. doi: 10.1016/j.jad.2007.03.002.
188. Cairney J, Veldhuizen S, Faulkner G, Schaffer A, Rodriquez MC. Bipolar disorder and leisure-time physical activity: results from a national survey of Canadians. Ment Health Phys Act. 2009;2:65-70. doi: 10.1016/j. mhpa.2009.09.003.
189. Farmer ME, Locke BZ, Mocicki EK, Dannenberg AL, Larson DB, Radloff LS. Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1988;128:1340-1351.
190. Berg MA, Waern M, Nyberg J, Pedersen NL, Bergh Y, Berg ND, Nilsson M, Kuhn HG, Tor K. Cardiovascular fitness in males at age 18 and risk of serious depression in adulthood: Swedish prospective population-based study. Br J Psychiatry. 2012;201:352-359. doi: 10.1192/bjp.bp.111.103416.
191. Strle A, Hler M, Pfister H, Mler AG, Hoyer J, Wittchen HU, Lieb R. Physical activity and prevalence and incidence of mental disorders in adolescents and young adults. Psychol Med. 2007;37:1657-1666. doi: 10.1017/S003329170700089X.
192. Jacka FN, Pasco JA, Mykletun A, Williams LJ, Nicholson GC, Kotowicz MA, Berk M. Diet quality in bipolar disorder in a population-based sample of women. J Affect Disord. 2011;129:332-337. doi: 10.1016/j. jad.2010.09.004.
193. Hill AM, Fleming JA, Kris-Etherton PM. The role of diet and nutritional supplements in preventing and treating cardiovascular disease. Curr Opin Cardiol. 2009;24:433-441. doi: 10.1097/HCO.0b013e32832f2fb1.
194. Lichtenstein AH. Nutrient supplements and cardiovascular disease: a heartbreaking story. J Lipid Res. 2009;50(suppl):S429-S433. doi: 10.1194/jlr.R800027-JLR200.
195. Parker G, Brotchie H. "D" for depression: any role for vitamin D "Food for Thought" II. Acta Psychiatr Scand. 2011;124:243-249. doi: 10.1111/j.1600-0447.2011.01705.x.
196. Cope EC, Levenson CW. Role of zinc in the development and treatment of mood disorders. Curr Opin Clin Nutr Metab Care. 2010;13:685-689. doi: 10.1097/MCO.0b013e32833df61a.
197. Murakami K, Sasaki S. Dietary intake and depressive symptoms: a systematic review of observational studies. Mol Nutr Food Res. 2010;54:471-488. doi: 10.1002/mnfr.200900157.
198. Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanct KL. Zinc in depression: a meta-analysis. Biol Psychiatry. 2013;74:872-878. doi: 10.1016/j.biopsych.2013.05.008.
199. Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM, Ferrucci L. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab. 2010;95:3225-3233. doi: 10.1210/jc.2010-0347.
200. Hberg G, Gustafsson SA, Hlstr T, Gustafsson T, Klawitter B, Petersson M. Depressed adolescents in a case-series were low in vitamin D and depression was ameliorated by vitamin D supplementation. Acta Paediatr. 2012;101:779-783. doi: 10.1111/j.1651-2227.2012.02655.x.
201. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med. 2011;364:2439-2450. doi: 10.1056/NEJMra1008153.
202. Baghai TC, Varallo-Bedarida G, Born C, Hner S, Sche C, Eser D, Rupprecht R, Bondy B, von Schacky C. Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index. J Clin Psychiatry. 2011;72:1242-1247. doi: 10.4088/JCP.09m05895blu.
203. Noaghiul S, Hibbeln JR. Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry. 2003;160:2222-2227.
204. McNamara RK, Jandacek R, Rider T, Tso P, Dwivedi Y, Pandey GN. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord. 2010;126:303-311. doi: 10.1016/j.jad.2010.03.015.
205. Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry. 2010;68:140-147. doi: 10.1016/j.biopsych.2010.03.018.
206. Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL. Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder. Lipids. 2008;43:1031-1038. doi: 10.1007/s11745-008-3224-z
207. Murakami K, Miyake Y, Sasaki S, Tanaka K, Arakawa M. Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus Child Health Study. Pediatrics. 2010;126:e623-e630. doi: 10.1542/peds.2009-3277.
208. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68:1056-1061.
209. Sarris J, Mischoulon D, Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry. 2012;73:81-86. doi: 10.4088/JCP.10r06710.
210. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006;163:1098-1100. doi: 10.1176/ajp.2006.163.6.1098.
211. Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr. 2009;63:1037-1040. doi: 10.1038/ejcn.2008.81.
212. Wozniak J, Biederman J, Mick E, Waxmonsky J, Hantsoo L, Best C, Cluette-Brown JE, Laposata M. Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol. 2007;17:440-447. doi: 10.1016/j. euroneuro.2006.11.006.
213. Kwak SM, Myung SK, Lee YJ, Seo HG; Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebocontrolled trials. Arch Intern Med. 2012;172:686-694. doi: 10.1001/archinternmed.2012.262.
214. Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA. 2009;302:1651-1657. doi: 10.1001/jama.2009.1487.
215. Ramsdale DR, Faragher EB, Bray CL, Bennett DH, Ward C, Beton DC. Smoking and coronary artery disease assessed by routine coronary arteriography. Br Med J (Clin Res Ed). 1985;290:197-200.
216. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med. 1996;2:41-45.
217. Ginsberg D, Hall S, Reus VI, Muz RF. Mood and depression diagnosis in smoking cessation. Exp Clin Psychopharmacol. 1995;3:389-395.
218. Almeida OP, Pfaff JJ. Depression and smoking amongst older general practice patients. J Affect Disord. 2005;86:317-321. doi: 10.1016/j. jad.2005.02.014.
219. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284:2606-2610.
220. Diaz FJ, James D, Botts S, Maw L, Susce MT, de Leon J. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disord. 2009;11:154-165. doi: 10.1111/j.1399-5618.2009.00664.x.
221. Lam TH, Stewart SM, Ho SY, Lai MK, Mak KH, Chau KV, Rao U, Salili F. Depressive symptoms and smoking among Hong Kong Chinese adolescents. Addiction. 2005;100:1003-1011. doi: 10.1111/j.1360-0443.2005.01092.x.
222. Goldstein BI, Birmaher B, Axelson DA, Goldstein TR, Esposito-Smythers C, Strober MA, Hunt J, Leonard H, Gill MK, Iyengar S, Grimm C, Yang M, Ryan ND, Keller MB. Significance of cigarette smoking among youths with bipolar disorder. Am J Addict. 2008;17:364-371. doi: 10.1080/10550490802266151.
223. Wilens TE, Biederman J, Milberger S, Hahesy AL, Goldman S, Wozniak J, Spencer TJ. Is bipolar disorder a risk for cigarette smoking in ADHD youth Am J Addict. 2000;9:187-195.
224. Upadhyaya HP, Deas D, Brady KT, Kruesi M. Cigarette smoking and psychiatric comorbidity in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2002;41:1294-1305. doi: 10.1097/00004583-200211000-00010.
225. Nishiyama M, Kimijima M, Muto T, Kimura K. Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders. Environ Health Prev Med. 2012;17:285-291. doi: 10.1007/s12199-011-0250-x.
226. Goldstein BI, Bukstein OG. Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention. J Clin Psychiatry. 2010;71:348-358. doi: 10.4088/JCP.09r05222gry.
227. Cornelius JR, Maisto SA, Martin CS, Bukstein OG, Salloum IM, Daley DC, Wood DS, Clark DB. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav. 2004;29:1035-1038. doi: 10.1016/j.addbeh.2004.02.056.
228. Kandel DB, Johnson JG, Bird HR, Canino G, Goodman SH, Lahey BB, Regier DA, Schwab-Stone M. Psychiatric disorders associated with substance use among children and adolescents: findings from the Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study. J Abnorm Child Psychol. 1997;25:121-132.
229. Clark DB, Pollock N, Bukstein OG, Mezzich AC, Bromberger JT, Donovan JE. Gender and comorbid psychopathology in adolescents with alcohol dependence. J Am Acad Child Adolesc Psychiatry. 1997;36:1195-1203. doi: 10.1097/00004583-199709000-00011.
230. Licht CM, de Geus EJ, van Dyck R, Penninx BW. Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol Psychiatry. 2010;68:861-868. doi: 10.1016/j.biopsych.2010.06.032.
231. Khan A, Faucett J, Morrison S, Brown WA. Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials. JAMA Psychiatry. 2013;70:1091-1099. doi: 10.1001/jamapsychiatry.2013.149.
232. Birmaher B, Brent D, Bernet W, Bukstein O, Walter H, Benson RS, Chrisman A, Farchione T, Greenhill L, Hamilton J, Keable H, Kinlan J, Schoettle U, Stock S, Ptakowski KK, Medicus J; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46:1503-1526. doi: 10.1097/chi.0b013e318145ae1c.
233. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lespance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation. 2008;118:1768-1775. doi: 10.1161/CIRCULATIONAHA.108.190769.
234. Mansoor B, Rengasamy M, Hilton R, Porta G, He J, Spirito A, Emslie GJ, Mayes TL, Clarke G, Wagner KD, Shamseddeen W, Birmaher B, Ryan N, Brent D. The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression. J Child Adolesc Psychopharmacol. 2013;23:458-467. doi: 10.1089/cap.2012.0095.
235. Mojtabai R. Antidepressant use and glycemic control. Psychopharmacology (Berl). 2013;227:467-477. doi: 10.1007/s00213-013-2972-5.
236. Chang HH, Chi MH, Lee IH, Tsai HC, Gean PW, Yang YK, Lu RB, Chen PS. The change of insulin levels after six weeks antidepressant use in drug-nae major depressive patients. J Affect Disord. 2013;150:295-299. doi: 10.1016/j.jad.2013.04.008.
237. Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA. A review of treating depression in diabetes: emerging findings. Psychosomatics. 2011;52:1-18. doi: 10.1016/j.psym.2010.11.007.
238. Jerrell JM, McIntyre RS, Tripathi A. Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder. Hum Psychopharmacol. 2011;26:451-459. doi: 10.1002/hup.1227.
239. Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents. Arch Gen Psychiatry. 2012;69:515-528. doi: 10.1001/archgenpsychiatry.2011.1508.
240. Correll CU, Sheridan EM, DelBello MP. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord. 2010;12:116-141. doi: 10.1111/j.1399-5618.2010.00798.x.
241. Jerrell JM. Neurological and cardiovascular adverse events associated with antimanic treatment in children and adolescents. CNS Neurosci Ther. 2010;16:25-31. doi: 10.1111/j.1755-5949.2009.00087.x.
242. Redden L, DelBello M, Wagner KD, Wilens TE, Malhotra S, Wozniak P, Vigna NV, Greco N 4th, Kovacs X, Abi-Saab W, Saltarelli M; Depakote ER Pediatric Mania Group. Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol. 2009;19:83-89. doi: 10.1089/cap.2008.0106.
243. Ahrens B, Mler-Oerlinghausen B, Schou M, Wolf T, Alda M, Grof E, Grof P, Lenz G, Simhandl C, Thau K. Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord. 1995;33:67-75.
244. Goldstein BI, Sassi R, Diler RS. Pharmacologic treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2012;21:911-939. doi: 10.1016/j.chc.2012.07.004.
245. Pfeifer JC, Kowatch RA, DelBello MP. Pharmacotherapy of bipolar disorder in children and adolescents: recent progress. CNS Drugs. 2010;24:575-593. doi: 10.2165/11533110-000000000-00000.
246. McIntyre RS, Jerrell JM. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. Arch Pediatr Adolesc Med. 2008;162:929-935. doi: 10.1001/archpedi.162.10.929.
247. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents [published correction appears in JAMA. 2009;302:2322]. JAMA. 2009;302:1765-1773. doi: 10.1001/jama.2009.1549.
248. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Obes Res. 2004;12:362-368.
249. Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, Beaulieu S, Yatham LN, Berk M; International Society for Bipolar Disorders. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009;11:559-595. doi: 10.1111/j.1399-5618.2009.00737.x.
250. Haupt DW, Rosenblatt LC, Kim E, Baker RA, Whitehead R, Newcomer JW. Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. Am J Psychiatry. 2009;166:345-353. doi: 10.1176/appi. ajp.2008.08030383.
251. Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, Campagna E, Newcomer JW. Metabolic screening in children receiving antipsychotic drug treatment [published correction appears in Arch Pediatr Adolesc Med. 2010;164:584]. Arch Pediatr Adolesc Med. 2010;164:344-351. doi: 10.1001/archpediatrics.2010.48.
252. Brauer R, Douglas I, Smeeth L. The association between antipsychotic agents and the risk of myocardial infarction: a systematic review. Br J Clin Pharmacol. 2011;72:871-878. doi: 10.1111/j.1365-2125.2011.04043.x.
253. Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM. Risk of incident diabetes among patients treated with statins: population based study. BMJ. 2013;346:f2610.
254. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol. 2002;5:401-412. doi: 10.1017/S1461145702003164.
255. Rapoport SI, Bosetti F. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder Arch Gen Psychiatry. 2002;59:592-596.
256. Lee HJ, Ertley RN, Rapoport SI, Bazinet RP, Rao JS. Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex. Neurochem Res. 2008;33:861-866. doi: 10.1007/s11064-007-9526-3.
257. O'Brien SM, Scott LV, Dinan TG. Antidepressant therapy and C-reactive protein levels. Br J Psychiatry. 2006;188:449-452. doi: 10.1192/bjp. bp.105.011015.
258. Callaghan RC, Khizar A. The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada. J Affect Disord. 2010;122:118-123. doi: 10.1016/j.jad.2009.06.029.
259. Kraepelin E. Manic-Depressive Insanity and Paranoia. Edinburgh, United Kingdom: Livingstone; 1921.
260. Ramsey CM, Leoutsakos JM, Mayer LS, Eaton WW, Lee HB. History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study. J Affect Disord. 2010;125:35-41. doi: 10.1016/j. jad.2009.12.024.
261. Merikangas KR, He JP, Burstein M, Swendsen J, Avenevoli S, Case B, Georgiades K, Heaton L, Swanson S, Olfson M. Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2011;50:32-45. doi: 10.1016/j. jaac.2010.10.006.
262. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L; on behalf of the American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129:1350-1369. doi: 10.1161/CIR.0000000000000019.
263. Correll CU. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47:9-20. doi: 10.1097/chi.0b013e31815b5cb1.
264. Correll CU. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. J Clin Psychiatry. 2008;69(suppl 4):26-36.
265. Goldstein TR, Goldstein BI, Mantz MB, Bailey B, Douaihy A. A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report. J Child Adolesc Psychopharmacol. 2011;21:275-280. doi: 10.1089/cap.2010.0104.
266. Delbello MP, Correll CU, Carlson GA, Carlson HE, Kratochvil CJ. Pharmacological management of bipolar disorder in a youth with diabetes. J Am Acad Child Adolesc Psychiatry. 2007;46:1375-1379. doi: 10.1097/chi.0b013e31813c69c9.
267. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M; Child Psychiatric Workgroup on Bipolar Disorder. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:213-235.
268. Cheung AH, Zuckerbrot RA, Jensen PS, Ghalib K, Laraque D, Stein RE; GLAD-PC Steering Group. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II: treatment and ongoing management [published correction appears in Pediatrics. 2008;121:227]. Pediatrics. 2007;120:e1313-e1326. doi: 10.1542/peds.2006-1395.
269. Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Young B, Peterson D, Rutter CM, McGregor M, McCulloch D. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363:2611-2620. doi: 10.1056/NEJMoa1003955.
270. Druss BG, von Esenwein SA, Compton MT, Rask KJ, Zhao L, Parker RM. A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. Am J Psychiatry. 2010;167:151-159. doi: 10.1176/appi.ajp.2009.09050691.
271. Kilbourne AM, Post EP, Nossek A, Drill L, Cooley S, Bauer MS. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. Psychiatr Serv. 2008;59:760-768. doi: 10.1176/appi.ps.59.7.760.